Pediatric Characteristics of 2019 Novel Coronavirus: Review of Available Published Literature

Abstract

Get full access to this article

View all access options for this article.

References

World Health Organization. WHO Director-General’s opening remarks at the mission briefing on COVID-19. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-mission-briefing-on-covid-19—12-march-2020. Accessed March 30, 2020.

World Health Organization. Coronavirus disease (COVID-19) situation dashboard. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd. Accessed March 18, 2020.

Centers for Disease Control and Prevention. Cases in US. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html. Accessed March 19, 2020.

McGoogan

. Characteristics of and Important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239-1242. doi:10.1001/jama.2020.2648

Chan

JFW

Yuan

Kok

, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514-523. doi:10.1016/S0140-6736(20)30154-9

Zhang

, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382:1663-1665. doi:10.1056/NEJMc2005073

Dong

, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China [published online March 16, 2020]. Pediatrics. doi:10.1542/peds.2020-0702

Zhu

Wang

Fang

, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9:51-60. doi:10.21037/tp.2020.02.06

Cui

Tian

Huang

, et al. A 55-day-old female infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage [published online March 17, 2020]. J Infect Dis. doi:10.1093/infdis/jiaa113

10.

Wang

Guo

Chen

, et al. A case report of neonatal COVID-19 infection in China [published online March 12, 2020]. Clin Infect Dis. doi:10.1093/cid/ciaa225

11.

Zhu

, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26:502-505. doi:10.1038/s41591-020-0817-4

12.

Hageman

. The coronavirus disease 2019 (COVID-19). Pediatr Ann. 2020;49:e99-e100. doi:10.3928/19382359-20200219-01.

13.

Cai

Lin

, et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features [published online February 28, 2020]. Clin Infect Dis. doi:10.1093/cid/ciaa198

14.

Xia

Shao

Guo

Peng

. Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults. Pediatr Pulmonol. 2020;55:1169-1174. doi:10.1002/ppul.24718

15.

Huang

Wang

, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. doi:10.1016/S0140-6736(20)30183-5

16.

Wang

, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069. doi:10.1001/jama.2020.1585

17.

Russell

Millar

Baillie

. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395:473-475. doi:10.1016/S0140-6736(20)30317-2

18.

Updated: WHO now doesn’t recommend avoiding ibuprofen for COVID-19 symptoms. https://www.sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-symptoms. Published March 17, 2020. Accessed March 19, 2020.

19.

Gilead Sciences. Gilead Sciences statement on the company’s ongoing response to the 2019 novel coronavirus (2019-nCoV). gilead.com/news-and-press/company-statements/gilead-sciences-statement-on-the-company-ongoing-response-to-the-2019-new-coronavirus. Published January 31, 2020. Accessed March 30, 2020.

20.

Yao

Zhang

, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [published online March 9, 2020]. Clin Infect Dis. doi:10.1093/cid/ciaa237

21.

Cortegiani

Ingoglia

Ippolito

Giarratano

Einav

. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 [published online March 10, 2020]. J Crit Care. doi:10.1016/J.JCRC.2020.03.005

22.

Cao

Wang

Wen

, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19 [published online March 18, 2020]. N Engl J Med. doi:10.1056/NEJMoa2001282

23.

Liu

Miller

. China approves use of Roche drug in battle against coronavirus complications. https://www.reuters.com/article/us-health-coronavirus-china-roche-hldg-idUSKBN20R0LF. Published March 4, 2020. Accessed March 19, 2020.